BioMed Realty Trust Receives LEED(R) Gold Certification at Center for Life Science | Boston

SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR), The Leading Provider of Environmentally Sustainable Real Estate to the Life Science Industry(R), announced today that the world's leading life science research center - the Center for Life Science | Boston in the Longwood Medical Area - has achieved Gold LEED(R) certification for Core and Shell from the U.S. Green Building Council (USGBC). The property is 91% leased to Beth Israel Deaconess Medical Center, Children's Hospital Boston, Dana Farber Cancer Institute, Immune Disease Institute, and Kowa Company, Ltd.

By granting this elite designation, the USGBC recognized the Center for Life Science | Boston for its design excellence in five key areas of human and environmental health: sustainable site development, water savings, energy efficiency, materials selection and indoor environmental quality.

The Center for Life Science | Boston is a 700,000+ square foot research center that includes laboratory and office space in the heart of Boston's Longwood Medical Area, surrounded by world class life science research institutions, hospitals, and biotechnology and pharmaceutical companies, including Harvard Medical School, Brigham and Women's Hospital, and Merck Research Laboratories Boston, along with the premier life science tenants of the Center for Life Science | Boston.

Commenting on the company's latest LEED(R) certification, Alan D. Gold, BioMed's Chairman and Chief Executive Officer, said, "I congratulate Team BioMed and all of our development partners at the Center for Life Science | Boston for this important accomplishment. Our business model is focused on building a world-class property portfolio in the seven core U.S. life science markets. Creating a successful, sustainable business extends to the buildings that we develop. Along with our tenants, we have worked hard to develop state-of-the-art research facilities that also meet the rigorous requirements of the USGBC's LEED(R) certification program."

In 1998, the USGBC established the LEED(R) Green Building Rating System(TM) as a third-party certification program that has become the nationally accepted benchmark for the design, construction and operation of high performance green buildings. BioMed has been a successful pioneer in bringing LEED(R)-certified projects to the life science industry:

• BioMed's 500 Kendall Street property in Cambridge, Massachusetts achieved Platinum LEED(R) certification, the highest rating available. This property is 100% leased to Genzyme Corporation and was recently awarded the Boston Society of Architects' Harleston Parker Medal, which recognizes "the single most beautiful" building or other structure built in the Metropolitan Boston area in the past ten years.
• The company's 84,000 square foot built-to-suit laboratory and office facility at its 9865 Towne Centre Drive campus in San Diego was completed in July, 2008 and received Silver LEED(R) certification. The property is 100% leased to Illumina, Inc.
• The 650 East Kendall Street building in Cambridge, Massachusetts, a 280,000 square foot joint venture development project between BioMed and Prudential Real Estate Investors, is scheduled for delivery later in 2009 and has received LEED(R) Gold pre-certification.

In addition, BioMed is in the process of obtaining LEED(R) certification for its 675 West Kendall Street building in Cambridge, Massachusetts which is 100% leased to Vertex Pharmaceuticals, and is targeting Gold LEED(R) certification.

Kent Griffin, BioMed's President and Chief Financial Officer, remarked, "With Gold certification for the Center for Life Science | Boston, we now have more than 1.2 million square feet of LEED(R)-certified laboratory and office space in the Cambridge/Boston market. We are seeing increased interest from prospective tenants in 'green' buildings, along with recent attention from state and federal government agencies that can provide financial support and other subsidies for life science organizations that occupy properties which include green/sustainable design elements."

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 69 properties, representing 112 buildings with approximately 10.4 million rentable square feet, including approximately 1.4 million square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.

About USGBC

The U.S. Green Building Council (USGBC) is a non-profit organization committed to expanding sustainable building practices. USGBC is composed of more than 15,000 organizations from across the building industry that are working to advance structures that are environmentally responsible, profitable, and healthy places to live and work. Members include building owners and end-users, real estate developers, facility managers, architects, designers, engineers, general contractors, subcontractors, product and building system manufacturers, government agencies, and nonprofits.

About LEED(R)

The Leadership in Energy and Environmental Design (LEED(R)) Green Building Rating System(TM) encourages and accelerates global adoption of sustainable green building and development practices through the creation and implementation of universally understood and accepted tools and performance criteria. LEED(R) is a third-party certification program and the nationally accepted benchmark for the design, construction and operation of high performance green buildings. LEED(R) gives building owners and operators the tools they need to have an immediate and measurable impact on their buildings' performance.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing, the use of debt to fund acquisitions and developments, and the ability to refinance indebtedness as it comes due; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; risks and uncertainties affecting property development and construction; risks associated with downturns in the national and local economies, increases in interest rates, and volatility in the securities markets; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE BioMed Realty Trust, Inc.